We developed an interpretable model, BOUND (Bayesian netwOrk for large-scale lUng caNcer Digital prescreening), using a comprehensive EHR dataset from the China to improve lung cancer detection rates. BOUND employs Bayesian network uncertainty inference,…
Continue Reading
What You Should Know:
– Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
– The partnership will expand…
Continue Reading
What You Should Know:
– MICA Artificial Intelligence and Baptist Health South Florida have joined forces in a groundbreaking collaboration to transform breast cancer detection.
– By integrating MICA AI’s innovative technology into mammography, the partnership…
Continue Reading
What You Should Know:
– CureMetrix, an innovator in AI-driven mammography solutions, has partnered with SimonMed Imaging, a prominent provider of outpatient medical imaging services in the United States.
– The strategic collaboration will bring CureMetrix’s…
Continue Reading
What You Should Know:
– PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing…
Continue Reading
What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract…
Continue Reading
The NHS is piloting an iPhone device and app that helps detect throat cancer earlier and give patients the all-clear for the disease faster.
An initial trial on triaged low-risk patients at University Hospitals of…
What You Should Know:
– Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
– This investment, co-led by Smart Family…
Continue Reading
Introduction
Artificial intelligence (AI) is transforming breast cancer detection by enhancing early diagnosis and alleviating radiologist workload, essential for improving patient outcomes and screening efficiency. A recent study, conducted by researchers from Norway and Denmark,…
What You Should Know:
– Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused…
Continue Reading
